Moderna refused China request to reveal vaccine technology – FT

Author of the article: Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter. The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request…
Moderna refused China request to reveal vaccine technology – FT

Author of the article:

Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter.

The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to hand over the recipe for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place between 2020 and 2021, adding that the vaccine maker is still “eager” to sell the product to China.

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

The company had “given up” on its previous efforts to access the Chinese market because of China’s demand that it hand over the technology as a prerequisite for selling in the country, the report said.

Moderna did not immediately respond to Reuters’ request for comment.

China has not approved any foreign COVID-19 vaccines and relies on several domestically developed shots.

In September, Moderna Chief Medical Officer Paul Burton had said the company was keen to collaborate with China on supplying its mRNA-based COVID-19 vaccines to the country.

“We would certainly be very eager to collaborate with China if they felt that there was a need for a vaccine there,” Burton had told a media briefing for reporters in Asia. “Currently, there is no activity going on, but we’d be very open to it.” (Reporting by Rhea Binoy in Bengaluru; editing by Jonathan Oatis)

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Integra Resources Announces Quarterly Grant of Deferred Share Units to Certain Directors
Read More

Integra Resources Announces Quarterly Grant of Deferred Share Units to Certain Directors

Author of the article: VANCOUVER, British Columbia, Dec. 31, 2021 (GLOBE NEWSWIRE) — Integra Resources Corp. (“Integra” or the “Company”) (TSX-V:ITR; NYSE American:ITRG) announces that it has granted a total of 8,651 deferred share units (the “DSUs”) to three directors of the Company in lieu of Q4 2021 directors’ cash fees. The DSUs have been…
U.S. security review stalls sale of Shell Texas refinery to Mexico’s Pemex
Read More

U.S. security review stalls sale of Shell Texas refinery to Mexico’s Pemex

Author of the article: HOUSTON — A U.S. national security review has delayed the sale of Royal Dutch Shell’s controlling interest in a Texas refinery to Mexico’s national oil company, Petroleos Mexicanos (Pemex), Shell said on Tuesday. Shell in May disclosed an agreement to sell its 50% interest in the 302,800-barrel-per-day (bpd) Deer Park, Texas,…
Hamilton Thorne Reports Financial and Operational Results for the Quarter and Six Months Ended June 30, 2022
Read More

Hamilton Thorne Reports Financial and Operational Results for the Quarter and Six Months Ended June 30, 2022

Author of the article: Revenues up 14% for the quarter and 18% for the six months despite supply chain issues and significant foreign currency swings BEVERLY, Mass. and TORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART),…